These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 11316875

  • 1. High-resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector.
    Safo MK, Moure CM, Burnett JC, Joshi GS, Abraham DJ.
    Protein Sci; 2001 May; 10(5):951-7. PubMed ID: 11316875
    [Abstract] [Full Text] [Related]

  • 2. Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats.
    Abraham DJ, Wireko FC, Randad RS, Poyart C, Kister J, Bohn B, Liard JF, Kunert MP.
    Biochemistry; 1992 Sep 29; 31(38):9141-9. PubMed ID: 1390701
    [Abstract] [Full Text] [Related]

  • 3. X-ray crystallographic analyses of symmetrical allosteric effectors of hemoglobin: compounds designed to link primary and secondary binding sites.
    Safo MK, Boyiri T, Burnett JC, Danso-Danquah R, Moure CM, Joshi GS, Abraham DJ.
    Acta Crystallogr D Biol Crystallogr; 2002 Apr 29; 58(Pt 4):634-44. PubMed ID: 11914488
    [Abstract] [Full Text] [Related]

  • 4. Aryloxyalkanoic Acids as Non-Covalent Modifiers of the Allosteric Properties of Hemoglobin.
    Omar AM, Mahran MA, Ghatge MS, Bamane FH, Ahmed MH, El-Araby ME, Abdulmalik O, Safo MK.
    Molecules; 2016 Aug 13; 21(8):. PubMed ID: 27529207
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and structure-activity relationships of chiral allosteric modifiers of hemoglobin.
    Phelps Grella M, Danso-Danquah R, Safo MK, Joshi GS, Kister J, Marden M, Hoffman SJ, Abraham DJ.
    J Med Chem; 2000 Dec 14; 43(25):4726-37. PubMed ID: 11123981
    [Abstract] [Full Text] [Related]

  • 6. Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents.
    Randad RS, Mahran MA, Mehanna AS, Abraham DJ.
    J Med Chem; 1991 Feb 14; 34(2):752-7. PubMed ID: 1995897
    [Abstract] [Full Text] [Related]

  • 7. Phase I trial to determine the safety, pharmacodynamics, and pharmacokinetics of RSR13, a novel radioenhancer, in newly diagnosed glioblastoma multiforme.
    Kleinberg L, Grossman SA, Piantadosi S, Pearlman J, Engelhard H, Lesser G, Ruffer J, Gerber M.
    J Clin Oncol; 1999 Aug 14; 17(8):2593-603. PubMed ID: 10561327
    [Abstract] [Full Text] [Related]

  • 8. RSR13, a synthetic allosteric modifier of hemoglobin, improves myocardial recovery following hypothermic cardiopulmonary bypass.
    Kilgore KS, Shwartz CF, Gallagher MA, Steffen RP, Mosca RS, Bolling SF.
    Circulation; 1999 Nov 09; 100(19 Suppl):II351-6. PubMed ID: 10567328
    [Abstract] [Full Text] [Related]

  • 9. Effect of an allosteric modifier of hemoglobin, RSR-4, on oxygen affinity and oxygen saturation of hemoglobin in rabbits.
    Uchida K, Reilly MP, Abraham DJ, Asakura T.
    Jpn J Physiol; 1998 Dec 09; 48(6):439-44. PubMed ID: 10021497
    [Abstract] [Full Text] [Related]

  • 10. Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease.
    Pagare PP, Ghatge MS, Musayev FN, Deshpande TM, Chen Q, Braxton C, Kim S, Venitz J, Zhang Y, Abdulmalik O, Safo MK.
    Bioorg Med Chem; 2018 May 15; 26(9):2530-2538. PubMed ID: 29655608
    [Abstract] [Full Text] [Related]

  • 11. Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo.
    Teicher BA, Wong JS, Takeuchi H, Gravelin LM, Ara G, Buxton D.
    Cancer Chemother Pharmacol; 1998 May 15; 42(1):24-30. PubMed ID: 9619754
    [Abstract] [Full Text] [Related]

  • 12. Synthesized allosteric effectors of the hemoglobin molecule: a possible mechanism for improved erythrocyte oxygen release capability in hemoglobinopathy H disease.
    Papassotiriou I, Kister J, Griffon N, Abraham DJ, Kanavakis E, Traeger-Synodinos J, Stamoulakatou A, Marden MC, Poyart C.
    Exp Hematol; 1998 Sep 15; 26(10):922-6. PubMed ID: 9728926
    [Abstract] [Full Text] [Related]

  • 13. Insights into the solution structure of human deoxyhemoglobin in the absence and presence of an allosteric effector.
    Sahu SC, Simplaceanu V, Gong Q, Ho NT, Tian F, Prestegard JH, Ho C.
    Biochemistry; 2007 Sep 04; 46(35):9973-80. PubMed ID: 17691822
    [Abstract] [Full Text] [Related]

  • 14. Effects of the allosteric modification of hemoglobin on brain oxygen and infarct size in a feline model of stroke.
    Watson JC, Doppenberg EM, Bullock MR, Zauner A, Rice MR, Abraham D, Young HF.
    Stroke; 1997 Aug 04; 28(8):1624-30. PubMed ID: 9259760
    [Abstract] [Full Text] [Related]

  • 15. Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds.
    Safo MK, Abdulmalik O, Danso-Danquah R, Burnett JC, Nokuri S, Joshi GS, Musayev FN, Asakura T, Abraham DJ.
    J Med Chem; 2004 Sep 09; 47(19):4665-76. PubMed ID: 15341482
    [Abstract] [Full Text] [Related]

  • 16. The crystal structure of bar-headed goose hemoglobin in deoxy form: the allosteric mechanism of a hemoglobin species with high oxygen affinity.
    Liang Y, Hua Z, Liang X, Xu Q, Lu G.
    J Mol Biol; 2001 Oct 12; 313(1):123-37. PubMed ID: 11601851
    [Abstract] [Full Text] [Related]

  • 17. RSR13, a synthetic allosteric modifier of hemoglobin, enhances recovery of stunned myocardium in dogs.
    Pagel PS, Hettrick DA, Montgomery MW, Kersten JR, Warltier DC.
    Adv Exp Med Biol; 1998 Oct 12; 454():527-31. PubMed ID: 9889932
    [No Abstract] [Full Text] [Related]

  • 18. Crystal structures of HbA2 and HbE and modeling of hemoglobin delta 4: interpretation of the thermal stability and the antisickling effect of HbA2 and identification of the ferrocyanide binding site in Hb.
    Sen U, Dasgupta J, Choudhury D, Datta P, Chakrabarti A, Chakrabarty SB, Chakrabarty A, Dattagupta JK.
    Biochemistry; 2004 Oct 05; 43(39):12477-88. PubMed ID: 15449937
    [Abstract] [Full Text] [Related]

  • 19. RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice.
    Khandelwal SR, Kavanagh BD, Lin PS, Truong QT, Lu J, Abraham DJ, Schmidt-Ullrich RK.
    Br J Cancer; 1999 Feb 05; 79(5-6):814-20. PubMed ID: 10070874
    [Abstract] [Full Text] [Related]

  • 20. X-ray diffraction study of di and tetra-ligated T-state hemoglobin from high salt crystals.
    Abraham DJ, Peascoe RA, Randad RS, Panikker J.
    J Mol Biol; 1992 Sep 20; 227(2):480-92. PubMed ID: 1404365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.